Si tienes curiosidad pero tambin dudas, el enfoque claro y fundamentado de la doctora Sowa es una lectura imprescindible
Molecular Analysis: Tirzepatide is a very large peptide molecule
The FDA approval of Zepbound is based on the results of the SURMOUNT-1 and Through these studies, researchers reported that over 72 weeks, participants who took the highest dose of Zepbound lost an average of 48 lbs, and those who took the lowest dose lost an average of 34 lbs
Keep in mind that there are versions of semaglutide and tirzepatide that are approved for either weight loss (Wegovy, Zepbound) or diabetes (Ozempic, Mounjaro), but not one version that's approved for both, even though effects should be the same between them
The most common side effects are gastrointestinal, including nausea (affecting 20-40% of patients), vomiting, diarrhoea, constipation, and abdominal discomfort
Looking after your overall health gives every treatment a better chance of working